Jennifer Kaiser Blase, MD
Obstetrics & Gynecology · Royal Oak, MINPI 1649486101
Payments from drug & device makers
Across 104 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$256
- AbbVie$253
- Astellas Pharma US Inc$249
- Myovant Sciences Inc.$171
- Sage Therapeutics, LLC$144
- Hologic Sales And Service, LLC$140
- plus $892 from 23 others
What the payments were for
- Food & beverage$2,00695%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $256 |
| AbbVie(2 entities) | 14 | $253 |
| Astellas Pharma US Inc | 10 | $249 |
| Myovant Sciences Inc. | 9 | $171 |
| Sage Therapeutics, LLC | 5 | $144 |
| Hologic Sales And Service, LLC | 6 | $140 |
| Exeltis, USA Inc. | 8 | $125 |
| Organon | 5 | $106 |
| Mayne Pharma Commercial LLC | 4 | $81 |
| Minerva Surgical, Inc | 2 | $63 |
| Bayer | 3 | $52 |
| Lupin Inc. | 3 | $50 |
| Coopersurgical, Inc. | 3 | $44 |
| Johnson & Johnson | 2 | $43 |
| Medtronic | 1 | $34 |
| Millicent US Inc | 2 | $32 |
| Ferring Pharmaceuticals Inc. | 1 | $30 |
| Dexcom, Inc. | 1 | $27 |
| Gynesonics, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Myriad Women's Health, Inc. | 1 | $23 |
| Pfizer | 1 | $20 |
| Channel Medsystems, Inc. | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Merck | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Dysis Medical, Inc. | 1 | $13 |
How this compares
$2,105 in reported general payments places this provider in the 80th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $1,089 |
| Clobetasol Propionate | 11 | $102 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Royal Oak
- Kurt WhartonRoyal Oak$35K
- Haider MahdiDetroit$3.4M
- Andrew WagnerMidland$2M
- Jason BellAnn Arbor$548K
- Jacquelyn RobinsonSaginaw$539K
- Jouhaina MalehDearborn$524K
- Awoniyi AwonugaSouthfield$445K
- Rabbie HannaDetroit$421K
- David EisensteinDetroit$296K
- Duane HeilbronnSaginaw$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.